Cognitive Disorders

Contributing journals to this collection:
JAMA & Archives Journals

Citations 111-120 of 483 total displayed.

Past content

Medical News & Perspectives
Studies Reveal Underlying Mechanism for Chemotherapy’s Adverse Effects on Brain

Tracy Hampton
JAMA 2008; 299: 2494. [Extract] [Full text] [PDF]  

Original Contributions
Plasma Amyloid β-Protein and C-reactive Protein in Relation to the Rate of Progression of Alzheimer Disease

Joseph J. Locascio; Hiroaki Fukumoto; Liang Yap; Teodoro Bottiglieri; John H. Growdon; Bradley T. Hyman; Michael C. Irizarry
Arch Neurol 2008; 65: 776-785. [Abstract] [Full text] [PDF]  

Original Contributions
Microbleed Topography, Leukoaraiosis, and Cognition in Probable Alzheimer Disease From the Sunnybrook Dementia Study

Jacqueline A. Pettersen; Gayathri Sathiyamoorthy; Fu-Qiang Gao; Gregory Szilagyi; Neelesh K. Nadkarni; Peter St George-Hyslop; Ekaterina Rogaeva; Sandra E. Black
Arch Neurol 2008; 65: 790-795. [Abstract] [Full text] [PDF]  

Off-Center Fold
Erosive Dermatitis and Progressive Neurological Symptoms—Diagnosis

Arch Dermatol 2008; 144: 795-c-800-c. [Extract] [Full text] [PDF]  

Off-Center Fold
Erosive Dermatitis and Progressive Neurological Symptoms—Quiz Case

Kim C. Nussbaum; Kathryn Colleen Barlow; Mark Allan Berk; Neha Robinson; Fred Levit
Arch Dermatol 2008; 144: 795-b-800-b. [Extract] [Full text] [PDF]  

Medical News & Perspectives
Researchers Identify Neurological Risks

Bridget M. Kuehn
JAMA 2008; 299: 2375-2376. [Extract] [Full text] [PDF]  

Clinical Trials
Cognitive Function Over Time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): Results of a Randomized, Controlled Trial of Naproxen and Celecoxib

ADAPT Research Group
Arch Neurol 2008.65.7.nct70006. [Abstract] [Full text] [PDF]  

Original Articles
Amyloid-Associated Depression: A Prodromal Depression of Alzheimer Disease?

Xiaoyan Sun; David C. Steffens; Rhoda Au; Marshal Folstein; Paul Summergrad; Jacqueline Yee; Irwin Rosenberg; D. Mkaya Mwamburi; Wei Qiao Qiu
Arch Gen Psychiatry 2008; 65: 542-550. [Abstract] [Full text] [PDF]  

Original Contributions
Cognitive and Anatomic Contributions of Metabolic Decline in Alzheimer Disease and Cerebrovascular Disease

Beth Kuczynski; Bruce Reed; Dan Mungas; Michael Weiner; Helena C. Chui; William Jagust
Arch Neurol 2008; 65: 650-655. [Abstract] [Full text] [PDF]  

Special Communications
Reporting Mortality Findings in Trials of Rofecoxib for Alzheimer Disease or Cognitive Impairment: A Case Study Based on Documents From Rofecoxib Litigation

Bruce M. Psaty; Richard A. Kronmal
JAMA 2008; 299: 1813-1817. [Abstract] [Full text] [PDF] [ JAMA Report Video ]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49